DCF — METRO NASHVILLE GENERAL HOSPITAL
Enterprise Value: $183.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$183.1M
Enterprise Value
$46.6M
PV of Cash Flows
$136.5M
PV of Terminal Value
$219.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $296.0M | $25.2M | 8.0% | $8.2M | $7.4M |
| Year 2 | $304.9M | $29.0M | 9.0% | $10.7M | $8.9M |
| Year 3 | $314.0M | $33.0M | 10.0% | $13.4M | $10.1M |
| Year 4 | $323.4M | $35.6M | 11.0% | $15.0M | $10.3M |
| Year 5 | $333.1M | $37.5M | 11.0% | $16.1M | $10.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $183.1M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$287.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07999999888641494
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5